Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SLEVIN, M. L")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 81

  • Page / 4
Export

Selection :

  • and

Quality of life : philosophical question or clinical reality ?SLEVIN, M. L.BMJ. British medical journal (International ed.). 1992, Vol 305, Num 6851, pp 466-469, issn 0959-8146Article

Etoposide dosage and pharmacodynamicsJOEL, S. P; RITA SHAH; SLEVIN, M. L et al.Cancer chemotherapy and pharmacology. 1994, Vol 34, pp S69-S75, issn 0344-5704, SUPConference Paper

Schedule-dependent topoisomerase II-inhibiting drugsJOEL, S. P; SLEVIN, M. L.Cancer chemotherapy and pharmacology. 1994, Vol 34, pp S84-S88, issn 0344-5704, SUPConference Paper

The clinical pharmacology of etoposide and teniposideCLARK, P. I; SLEVIN, M. L.Clinical pharmacokinetics. 1987, Vol 12, Num 4, pp 223-252, issn 0312-5963Article

Prolonged oral etoposide in small cell lung cancerSLEVIN, M. L; JOEL, S. P.Annals of oncology. 1993, Vol 4, Num 7, pp 529-532, issn 0923-7534Article

Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary : a new therapeutic approach ?MALIK, S. T. A; SLEVIN, M. L.British journal of cancer. 1991, Vol 63, Num 3, pp 410-411, issn 0007-0920Article

Successful pregnancy after treatment of stage III bilateral ovarian dysgerminomaHUDSON, C. N; SLEVIN, M. L; TEBBUTT, H et al.British journal of obstetrics and gynaecology (Print). 1995, Vol 102, Num 12, pp 1015-1016, issn 0306-5456Article

Randomized trials in cancer: a critical review by sitesSLEVIN, M. L; STAQUET, M. J.Monograph series of the European Organization for Research on Treatment of Cancer. 1986, Vol 15, issn 0146-0447, 701 p.Serial Issue

Ambulatory chemotherapySEYMOUR, M. T; SLEVIN, M. L.Clinical oncology. 1992, Vol 4, Num 1, pp 1-3Article

Allopurinol mouthwashes and 5-fluorouracil induced oral toxicityCLARK, P. I; SLEVIN, M. L.European journal of surgical oncology. 1985, Vol 11, Num 3, pp 267-268, issn 0748-7983Article

Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancerPEPPERCORN, P. D; REZNEK, R. H; WILSON, P et al.British journal of cancer. 1998, Vol 77, Num 11, pp 2008-2011, issn 0007-0920Article

A randomized trial of two etoposide schedules in small-cell lung cancer : the influence of pharmacokinetics on efficacy and toxicityCLARK, P. I; SLEVIN, M. L; JOEL, S. P et al.Journal of clinical oncology. 1994, Vol 12, Num 7, pp 1427-1435, issn 0732-183XArticle

Attitudes to chemotherapy : comparing views of patients with cancer with those of doctors, nurses, and general publicfSLEVIN, M. L; STUBBS, L; PLANT, H. J et al.BMJ. British medical journal (International ed.). 1990, Vol 300, Num 6737, pp 1458-1460, issn 0959-8146Article

BACUP ― the first two years: evaluation of a national cancer information serviceSLEVIN, M. L; TERRY, Y; HALLETT, N et al.British medical journal (1857). 1988, Vol 297, Num 6649, pp 669-672, issn 0007-1447Article

High-dose cytarabine in small cell lung cancerOSBORNE, R. J; CLARK, P. I; SLEVIN, M. L et al.Cancer treatment reports. 1987, Vol 71, Num 4, pp 417-418, issn 0361-5960Article

Phase II study of vinblastine and bleomycin in advanced ovarian cancerOSBORNE, R. J; HARVEY, V. J; SLEVIN, M. L et al.Cancer treatment reports. 1987, Vol 71, Num 3, pp 335-336, issn 0361-5960Article

An improved method for the simultaneous determination of morphine and its principal glucuronide metabolitesJOEL, S. P; OSBORNE, R. J; SLEVIN, M. L et al.Journal of chromatography. 1988, Vol 430, Num 2, pp 394-399, issn 0021-9673Article

Respiratory depression following morphine and morphine-6-glucuronide in normal subjectsTHOMPSON, P. I; JOEL, S. P; JOHN, L et al.British journal of clinical pharmacology. 1995, Vol 40, Num 2, pp 145-152, issn 0306-5251Conference Paper

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancerJOHNSON, P. W. M; JOEL, S. P; LOVE, S et al.British journal of cancer. 1993, Vol 67, Num 4, pp 760-766, issn 0007-0920Article

The treatment of microscopic residual ovarian cancer with intraperitoneal interferon : a clinical and flow cytometric studyWHELAN, J. S; VAN DAM, P. A; SHEPHERD, J. H et al.British journal of obstetrics and gynaecology (Print). 1992, Vol 99, Num 7, pp 615-617, issn 0306-5456Article

Phase II trial of UFT in advanced colorectal and gastric cancerMALIK, S. T. A; TALBOT, D; CLARKE, P. I et al.British journal of cancer. 1990, Vol 62, Num 6, pp 1023-1025, issn 0007-0920, 3 p.Article

TNO6 in non small cell lung cancerOSBORNE, R. J; SLEVIN, M. L; WRIGLEY, P. F. M et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 1, pp 109-110, issn 0277-5379Article

A phase II study of tamoxifen in ovarian cancerSLEVIN, M. L; HARVEY, V. J; OSBORNE, R. J et al.European journal of cancer & clinical oncology. 1986, Vol 22, Num 3, pp 309-312, issn 0277-5379Article

Delayed-release bleomycin: comparative pharmacology of bleomycin oil suspension and bleomycin in salineSLEVIN, M. L; HARVEY, V. J; AHERNE, G. W et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 1, pp 19-21, issn 0344-5704Article

Stability of the i.v. and oral formulations of etoposide in solutionJOEL, S. P; CLARK, P. I; SLEVIN, M. L et al.Cancer chemotherapy and pharmacology. 1995, Vol 37, Num 1-2, pp 117-124, issn 0344-5704Article

  • Page / 4